212 related articles for article (PubMed ID: 31960163)
1. A single-center experience in the management of head and neck lymphangiomas.
Aluffi Valletti P; Brucoli M; Boffano P; Benech A; Toso A; Dell'Era V; Garzaro M
Oral Maxillofac Surg; 2020 Mar; 24(1):109-115. PubMed ID: 31960163
[TBL] [Abstract][Full Text] [Related]
2. [Lymphatic malformations in the head and neck: experiences with sclerotherapy].
Knipping S; Bau V
HNO; 2011 Jul; 59(7):683-8. PubMed ID: 21509618
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective - A retrospective case series.
Fasching G; Dollinger C; Spendel S; Tepeneu NF
Ann Med Surg (Lond); 2022 Sep; 81():104531. PubMed ID: 36147081
[TBL] [Abstract][Full Text] [Related]
4. OK-432 therapy for lymphangiomas.
Smith RJ; Burke DK; Sato Y; Poust RI; Kimura K; Bauman NM
Arch Otolaryngol Head Neck Surg; 1996 Nov; 122(11):1195-9. PubMed ID: 8906054
[TBL] [Abstract][Full Text] [Related]
5. [Management of lymphatic malformations in oral and maxillofacial regions: the rationale according to the new classification].
Zheng JW; Qin ZP; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2005 Dec; 14(6):553-6. PubMed ID: 16400476
[TBL] [Abstract][Full Text] [Related]
6. Sclerosing treatment of lymphangiomas with OK-432.
Luzzatto C; Midrio P; Tchaprassian Z; Guglielmi M
Arch Dis Child; 2000 Apr; 82(4):316-8. PubMed ID: 10735841
[TBL] [Abstract][Full Text] [Related]
7. Treatment of lymphangiomas with OK-432 (Picibanil).
Rautio R; Keski-Nisula L; Laranne J; Laasonen E
Cardiovasc Intervent Radiol; 2003; 26(1):31-6. PubMed ID: 12491020
[TBL] [Abstract][Full Text] [Related]
8. OK-432 sclerotherapy of lymphatic malformation in the head and neck: factors related to outcome.
Kim DW
Pediatr Radiol; 2014 Jul; 44(7):857-62. PubMed ID: 24569928
[TBL] [Abstract][Full Text] [Related]
9. OK-432 (Picibanil) therapy for lymphangiomas in children.
Laranne J; Keski-Nisula L; Rautio R; Rautiainen M; Airaksinen M
Eur Arch Otorhinolaryngol; 2002 May; 259(5):274-8. PubMed ID: 12107533
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of OK-432 sclerotherapy for different types of lymphangiomas: a review and meta-analysis.
Sun J; Wang C; Song D; Wu C; Guo L
Braz J Otorhinolaryngol; 2023; 89(4):101270. PubMed ID: 37331237
[TBL] [Abstract][Full Text] [Related]
11. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial.
Giguère CM; Bauman NM; Sato Y; Burke DK; Greinwald JH; Pransky S; Kelley P; Georgeson K; Smith RJ
Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1137-44. PubMed ID: 12365884
[TBL] [Abstract][Full Text] [Related]
12. [Mixed facial lymphatic malformation: case report].
Morovic I CG; Vidal T C; Leiva V N; Véliz M S
Rev Chil Pediatr; 2014 Dec; 85(6):714-9. PubMed ID: 25697618
[TBL] [Abstract][Full Text] [Related]
13. OK-432 therapy for cervical lymphangioma.
Sichel JY; Udassin R; Gozal D; Koplewitz BZ; Dano I; Eliashar R
Laryngoscope; 2004 Oct; 114(10):1805-9. PubMed ID: 15454776
[TBL] [Abstract][Full Text] [Related]
14. [Experience with OK-432 in lymphatic vascular malformations in a hospital from northern Mexico].
Reyes JAC; Escurra EAM; Rangel JC; Ita JR; Lindemann JL; García LFR; López BJC
Bol Med Hosp Infant Mex; 2018; 75(2):89-93. PubMed ID: 29658945
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy.
Greinwald JH; Burke DK; Sato Y; Poust RI; Kimura K; Bauman NM; Smith RJ
Otolaryngol Head Neck Surg; 1999 Oct; 121(4):381-7. PubMed ID: 10504592
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin sclerotherapy in lymphangiomas of the head and neck region: a prospective study.
Tiwari P; Pandey V; Bera RN; Sharma SP; Chauhan N
Int J Oral Maxillofac Surg; 2021 May; 50(5):619-626. PubMed ID: 33059994
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
[TBL] [Abstract][Full Text] [Related]
18. OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result.
Yoo JC; Ahn Y; Lim YS; Hah JH; Kwon TK; Sung MW; Kim KH
Otolaryngol Head Neck Surg; 2009 Jan; 140(1):120-3. PubMed ID: 19130974
[TBL] [Abstract][Full Text] [Related]
19. Sclerotheraphy with OK-432 for the Treatment of Lymphangiomas.
Wang YG; Seo HI; Kim HY
Cancer Res Treat; 2002 Feb; 34(1):62-6. PubMed ID: 26680845
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic Malformation Architecture: Implications for Treatment With OK-432.
Malic CC; Guilfoyle R; Courtemanche RJM; Arneja JS; Heran MKS; Courtemanche DJ
J Craniofac Surg; 2017 Oct; 28(7):1721-1724. PubMed ID: 28834841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
